Hide metadata

dc.date.accessioned2020-02-17T19:42:22Z
dc.date.available2020-02-17T19:42:22Z
dc.date.created2019-01-09T13:19:29Z
dc.date.issued2019
dc.identifier.citationBjørnsen, Elisabeth Gyllensten Thiruchelvam-Kyle, Lavanya Hoelsbrekken, Sigurd Erik Henden, Camilla Sæther, Per Christian Boysen, Preben Daws, Michael Rory Dissen, Erik . B7H6 is a functional ligand for NKp30 in rat and cattle and determines NKp30 reactivity toward human cancer cell lines. European Journal of Immunology. 2018, 49(1), 54-65
dc.identifier.urihttp://hdl.handle.net/10852/73130
dc.description.abstractNK cells kill cancer cells and infected cells upon activation by cell surface receptors. Human NKp30 is an activating receptor expressed by all mature NK cells. The B7 family member B7H6 has been identified as one ligand for NKp30. Several alternative ligands have also been reported, and the field remains unsettled. To this end, we have identified full‐length functional B7H6 orthologs in rat and cattle, demonstrated by phylogenetic analysis and transfection experiments. In cell–cell contact‐dependent assays, chimeric NKp30 reporter cells responded strongly to B7H6 in rat and cattle. Likewise, rat NKp30 expressing target cells induced strong activation of B7H6 reporter cells. Together, these observations demonstrate that B7H6 is conserved as a functional ligand for NKp30 in mammalian species separated by more than 100 million years of evolution. B7H6 and NKp30 are pseudogenes in laboratory mice. The rat thus represents an attractive experimental animal model to study the NKp30‐B7H6 interaction in vivo. B7H6 was widely expressed among human cancer cell lines, and the expression level correlated strongly with the activation of human NKp30 reporter cells. Furthermore, siRNA knockdown of B7H6 abolished NKp30 reporter responses, suggesting that B7H6 is the major functionally relevant expressed ligand for NKp30 on these cancer cell lines.
dc.description.abstractB7H6 is a functional ligand for NKp30 in rat and cattle and determines NKp30 reactivity toward human cancer cell lines
dc.description.abstractNK cells kill cancer cells and infected cells upon activation by cell surface receptors. Human NKp30 is an activating receptor expressed by all mature NK cells. The B7 family member B7H6 has been identified as one ligand for NKp30. Several alternative ligands have also been reported, and the field remains unsettled. To this end, we have identified full‐length functional B7H6 orthologs in rat and cattle, demonstrated by phylogenetic analysis and transfection experiments. In cell–cell contact‐dependent assays, chimeric NKp30 reporter cells responded strongly to B7H6 in rat and cattle. Likewise, rat NKp30 expressing target cells induced strong activation of B7H6 reporter cells. Together, these observations demonstrate that B7H6 is conserved as a functional ligand for NKp30 in mammalian species separated by more than 100 million years of evolution. B7H6 and NKp30 are pseudogenes in laboratory mice. The rat thus represents an attractive experimental animal model to study the NKp30‐B7H6 interaction in vivo. B7H6 was widely expressed among human cancer cell lines, and the expression level correlated strongly with the activation of human NKp30 reporter cells. Furthermore, siRNA knockdown of B7H6 abolished NKp30 reporter responses, suggesting that B7H6 is the major functionally relevant expressed ligand for NKp30 on these cancer cell lines.
dc.languageEN
dc.titleB7H6 is a functional ligand for NKp30 in rat and cattle and determines NKp30 reactivity toward human cancer cell lines
dc.typeJournal article
dc.creator.authorBjørnsen, Elisabeth Gyllensten
dc.creator.authorThiruchelvam-Kyle, Lavanya
dc.creator.authorHoelsbrekken, Sigurd Erik
dc.creator.authorHenden, Camilla
dc.creator.authorSæther, Per Christian
dc.creator.authorBoysen, Preben
dc.creator.authorDaws, Michael Rory
dc.creator.authorDissen, Erik
cristin.unitcode185,51,12,37
cristin.unitnameNK-celle-gruppen
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.qualitycode2
dc.identifier.cristin1653222
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=European Journal of Immunology&rft.volume=49&rft.spage=54&rft.date=2018
dc.identifier.jtitleEuropean Journal of Immunology
dc.identifier.volume49
dc.identifier.issue1
dc.identifier.startpage54
dc.identifier.endpage65
dc.identifier.doihttps://doi.org/10.1002/eji.201847746
dc.identifier.urnURN:NBN:no-76243
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn0014-2980
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/73130/1/eji.201847749%2BDUO%2Bpostprint.pdf
dc.type.versionAcceptedVersion
dc.relation.projectNFR/196398
dc.relation.projectKF/63846
dc.relation.projectKF/113191


Files in this item

Appears in the following Collection

Hide metadata